Taft Stettinius & Hollister advised ONL Therapeutics on the transaction, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters.ONL Therapeutics, Inc. announced the…
ONL Therapeutics’ $65 Million Series D Financing Round


Taft Stettinius & Hollister advised ONL Therapeutics on the transaction, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters.ONL Therapeutics, Inc. announced the…
…